Cell
ArticleThe polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16
References (56)
- et al.
Basic alignment search tool
J. Mol. Biol.
(1990) - et al.
Improved early diagnosis of adult polycystic kidney disease with flanking DNA markers
Lancet
(1987) - et al.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Anal. Biochem.
(1987) Autosomal dominant polycystic kidney disease: more than a renal disease
Am. J. Kidney Dis.
(1990)Polycystic kidney disease: clues to pathogenesis
Kidney Int.
(1991)- et al.
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
Kidney Int.
(1992) - et al.
The gene for autosomal dominant polycystic kidney disease lies in a 750-kb CpG-rich region
Genomics
(1992) - et al.
A long-range restriction map between the α-globin complex and a marker closely linked to the polycystic kidney disease 1 (PKD1) locus
Genomics
(1990) - et al.
Rapid genetic analysis of families with polycystic kidney disease 1 by means of a microsatellite marker
Lancet
(1991) - et al.
Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13–q23
Genomics
(1993)
Liver cysts in patients with autosomal dominant polycystic kidney disease
Am. J. Med.
Treatable complications in undiagnosed cases of autosomal dominant polycystic kidney disease
Lancet
Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease
Lancet
Regional localization of the autosomal dominant polycystic kidney disease locus
Genomics
Fine genetic localization of the gene for autosomal dominant polycystic kidney disease (PKD1) with respect to physically mapped markers
Genomics
Isolation and characterization of (AC)n microsatellite genetic markers from human chromosome 16
Genomics
Tubulocystic epithelium
Kidney Int.
Refined mapping of the gene causing familial Mediterranean fever, by linkage and homozygosity studies
Am. J. Hum. Genet.
Map of 16 polymorphic loci on the short arm of chromosome 16 close to the polycystic kidney disease gene (PKD1)
J. Med. Genet.
X chromosome inactivation of the human TIMP gene
Nucl. Acids Res.
Fluorescent in situ hybridisation
Intracranial aneurysms in autosomal dominant polycystic kidney disease
N. Engl. J. Med.
Bilateral polycystic disease of the kidneys: a follow-up of two hundred and eighty-four patients and their families
Acta Med. Scand. (Suppl.)
Polycystic kidney disease re-evaluated: a population-based study
Quart. J. Med.
Activation of phenotypic expression of human globin genes from non-erythroid cells by chromo-some-dependent transfer to tetraploid mouse erythroleukemia cells
Locus assignment of human α globin mutations by selective amplification and direct sequencing
Br. J. Haemat.
Identification and characterization of the tuberous sclerosis gene on chromosome 16
Cell
Characteristics of very early onset autosomal dominant polycystic kidney disease
J. Am. Soc. Nephrol.
Cited by (778)
Transcriptomic profiling of Polycystic Kidney Disease identifies paracrine factors in the early cyst microenvironment
2024, Biochimica et Biophysica Acta - Molecular Basis of DiseaseCalcium signaling in polycystic kidney disease- cell death and survival
2023, Cell CalciumDevelopmental and Inherited Liver Disease
2023, MacSween's Pathology of the Liver, Eighth EditionGermline Mutations for Kidney Volume in ADPKD
2022, Kidney International Reports
- ★
The European Polycystic Kidney Disease Consortium is comprised of the following groups:
Group 1: Christopher J. Ward, Belén Peral, Jim Hughes, Sandra Thomas, Vicki Gamble, Angela B. MacCarthy, Jackie Sloane-Stanley, Veronica J. Buckle, Lyndal Kearney, Douglas R. Higgs, Peter J. Ratcliffe, and Peter C. Harris†
Medical Research Council Molecular Haematology Unit Institute of Molecular Medicine John Radcliffe Hospital Headington, Oxford OX3 9DU England
Group 2: Jeroen H. Roelfsema, Lia Spruit, Jasper J. Saris, Hans G. Dauwerse, Dorien J. M. Peters, and Martijn H. Breuning
Department of Human Genetics Leiden University 2333 AL Leiden The Netherlands
Group 3: Mark Nellist,1 Phillip T. Brook-Carter,1 Magitha M. Maheshwar,1 Isabel Cordeiro,2 Heloisa Santos,2 Pedro Cabral,3 and Julian R. Sampson1
1Institute of Medical Genetics University of Wales College of Medicine Cardiff CF4 4XN Wales
2Genetics Unit Hospital Santa Maria
3Department of Neurology Hospital D. Estefânia 1699 Lisbon Portugal
Group 4: Bart Janssen, Arjenne L. W. Hesseling-Janssen, Ans M. W. van den Ouweland, Bert Eussen, Senno Verhoef, Dick Lindhout, and Dicky J. J. Halley
Department of Clinical Genetics Erasmus University and University Hospital 3015 GE Rotterdam The Netherlands
†Correspondence should be addressed to Peter C. Harris.